azacitidine has been researched along with Meningeal Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Feige, U; Hamed, E; Hanft, KM; Hettmer, S; Kaiser, M; Krengel, S; Meiss, F; Niemeyer, C; Pietsch, T; Schneider, M; Würtemberger, J | 1 |
Brokinkel, B; Bunk, EC; Canisius, J; Eich, HT; Grauer, OM; Paulus, W; Senner, V; Spille, DC; Stummer, W; Thomas, C; Wagner, A | 1 |
Alshareef, M; Cachia, D; Das, A; Henderson, F; Infinger, L; Lindhorst, SM; Martinez Santos, JL; Patel, SJ; Vandergrift, WA; Varma, AK | 1 |
3 other study(ies) available for azacitidine and Meningeal Neoplasms
Article | Year |
---|---|
Combinatorial effects of azacitidine and trametinib on NRAS-mutated melanoma.
Topics: Azacitidine; Child, Preschool; GTP Phosphohydrolases; Humans; Male; Melanoma; Membrane Proteins; Meningeal Neoplasms; Mitogen-Activated Protein Kinase Kinases; Mutation; Nevus, Pigmented; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Skin Neoplasms | 2022 |
Molecular predictors for decitabine efficacy in meningiomas - a pilot study.
Topics: Azacitidine; Cell Line, Tumor; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Humans; Ki-67 Antigen; Meningeal Neoplasms; Meningioma; Myelin and Lymphocyte-Associated Proteolipid Proteins; Pilot Projects | 2023 |
Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth.
Topics: Aged; Anaplasia; Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; bcl-2-Associated X Protein; Cell Death; Decitabine; DNA Methylation; Down-Regulation; Gene Knockdown Techniques; Heptanoic Acids; Humans; In Vitro Techniques; Lanosterol; Matrix Metalloproteinase 9; Meningeal Neoplasms; Meningioma; Mice; Mice, SCID; Middle Aged; Molecular Targeted Therapy; Neoplasm Grading; Phosphatidylinositol 3-Kinases; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Triterpenes; Tumor Suppressor Proteins; Wnt2 Protein; Xenograft Model Antitumor Assays | 2020 |